Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03124758 · ClinicalTrials.gov registry record · NA
Accuracy of Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI)
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 354
- Enrollment target
NCT03124758: Completed NA study, sponsored by Masimo Corporation.
NCT03124758 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 354 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03124758, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 354 participants
- Enrollment target
Study Summary
In this study, the accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory hematology analyzer. Blood samples are collected from healthy volunteers who are enrolled in either a blood draw procedure or a hemodilution procedure wherein blood is repeatedly sampled as the concentration of hemoglobin is reduced in a controlled manner by administering fluids intravenously.
Primary Outcome
Accuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.
Interventions
- DEVICE Hemoglobin Sensor ((Rainbow Reusable DCI, DCIP))
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 2010-04-20 |
| Est. Completion | 2011-10-31 |
| Phase | NA |
What the finished NCT03124758 record still lists
NCT03124758 is an interventional study that assigns participants to a tested intervention. The registered 354 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 1 intervention - of which Hemoglobin Sensor ((Rainbow Reusable DCI, DCIP)) is the first listed.
NCT03124758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03124758 about?
NCT03124758 is a clinical study titled "Accuracy of Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI)". In this study, the accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory hematology analyzer. Blood samples are collected from healthy volunteers who are enrolled in either a blood draw procedure or a hemodilution procedure wherein...
What is the current status of trial NCT03124758?
This trial is currently completed. It is a NA study. The enrollment target is 354 participants. The study started on 2010-04-20. Estimated completion is 2011-10-31.
What interventions are being tested in trial NCT03124758?
The interventions under investigation include: Hemoglobin Sensor ((Rainbow Reusable DCI, DCIP)) (DEVICE).
Who is sponsoring clinical trial NCT03124758?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03124758's enrollment target sits among peer trials
354 291st of 2000 higher than 1,709 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02579967 · 354 participants · Phase 2
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- NCT02610413 · 354 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
- NCT05729256 · 354 participants · NA
Alcohol and "Heat of the Moment" Sexual Decision Making
- NCT06507618 · 354 participants · Phase 3
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI